Letermovir prophylaxis guided by cytomegalovirus cell-mediated immunity improves the outcomes of allogeneic hematopoietic stem cell transplant recipients. (PubMed, Clin Infect Dis) - Jul 24, 2025 - "CMV-CMI-guided letermovir prophylaxis may help reduce the risk of late-onset cs-CMVi, particularly in individuals at high risk."
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Transplantation
|
|
Chuanhe Jiang; Haiyang Lu; Jiayu Huang; Jingtao Huang; Jun Zhu; Luxiang Wang; Meijuan Huang; Qi Chen; Su Li; Xiaojia Guo; Xiaoxia Hu; Yang Cao; Yang He; Zengkai Pan; Zilu Zhang
|